Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient.
<h4>Background</h4>Neural stem cells are currently being investigated as potential therapies for neurodegenerative diseases, stroke, and trauma. However, concerns have been raised over the safety of this experimental therapeutic approach, including, for example, whether there is the pote...
Guardado en:
Autores principales: | Ninette Amariglio, Abraham Hirshberg, Bernd W Scheithauer, Yoram Cohen, Ron Loewenthal, Luba Trakhtenbrot, Nurit Paz, Maya Koren-Michowitz, Dalia Waldman, Leonor Leider-Trejo, Amos Toren, Shlomi Constantini, Gideon Rechavi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4e478578374944a7a1165c1f52756dbd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An anaplerotic approach to correct the mitochondrial dysfunction in ataxia-telangiectasia (A-T)
por: A.J. Yeo, et al.
Publicado: (2021) -
ATM Kinase Dead: From Ataxia Telangiectasia Syndrome to Cancer
por: Sabrina Putti, et al.
Publicado: (2021) -
MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated
por: Michal Smida, et al.
Publicado: (2016) -
A novel, ataxic mouse model of ataxia telangiectasia caused by a clinically relevant nonsense mutation
por: Harvey Perez, et al.
Publicado: (2021) -
Exposure of the cytoplasm to low-dose X-rays modifies ataxia telangiectasia mutated-mediated DNA damage responses
por: Munetoshi Maeda, et al.
Publicado: (2021)